Successful Erwinia asparaginase one-bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia

Pediatr Blood Cancer. 2022 May;69(5):e29632. doi: 10.1002/pbc.29632. Epub 2022 Mar 2.

Authors

Amanie Khairullah¹, Thomas B Alexander², Kathleen Wang³, Jenna Bognaski Kaplan¹

Affiliations

¹ Department of Pharmacy, UNC Health Care, Chapel Hill, North Carolina, USA.
² Pediatric Hematology-Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
³ Pediatric Allergy and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.

PMID: 35234336
DOI: 10.1002/pbc.29632

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Acute Disease
Asparaginase
Child
Erwinia*
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy

Substances

Asparaginase

Grants and funding

K12 CA120780/CA/NCI NIH HHS/United States